Gene · 5685
Papers825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Genome-Wide to Explore the Formation and Development Targets for Intracranial Aneurysms. | FASEB J | 2026 | 42698337 | PubTator, text mining | PubMed |
| From locus to gene: causal inference and experimental validation prioritize PSMA4 as a candidate target in lung adenocarcinoma. | Am J Cancer Res | 2026 | 42163891 | PubTator, text mining | PubMed |
| Identification of PSMA4 as a Therapeutic Target for Atherosclerosis: A Comprehensive Multiomics Mendelian Randomization Analysis. | Ann Hum Genet | 2026 | 42032825 | PubTator, text mining | PubMed |
| A comparative analysis of serum and tissue proteomic profiles in non-small cell lung cancer patients with or without brain metastasis. | Cell Death Discov | 2026 | 41974650 | PubTator, text mining | PubMed |
| Integrating genome-wide association studies with quantitative trait loci prioritised PSMA4 as a risk gene for pneumonia. | ERJ Open Res | 2026 | 41953759 | PubTator, text mining | PubMed |
| Exploring the shared genetic architecture between periodontitis and cardiovascular disease. | BDJ Open | 2026 | 41916952 | PubTator, text mining | PubMed |
| Machine learning and single-cell RNA sequencing analyses identify MS-related monocytes and a five-gene candidate biomarker signature. | Front Neurol | 2026 | 41756175 | PubTator, text mining | PubMed |
| Proteomic Insights into Venous Thromboembolism. | Med Sci (Basel) | 2026 | 41718141 | PubTator, text mining | PubMed |
| PSMA4 as a Druggable Target in Hidradenitis Suppurativa: Evidence From Mendelian Randomization and Single-Cell Transcriptomics. | Mediators Inflamm | 2026 | 41685341 | PubTator, text mining | PubMed |
| Identifying Therapeutic Targets for Bronchial Asthma: Systematic Druggable Genome-Wide Mendelian Randomization. | Health Sci Rep | 2026 | 41573111 | PubTator, text mining | PubMed |
| Multiomics analyses prioritize disease genes and pathways in hidradenitis suppurativa. | J Invest Dermatol | 2026 | 41548865 | PubTator, text mining | PubMed |
| Whole genome sequence analysis of pulmonary function and COPD in 44,287 multi-ancestry participants. | Genome Biol | 2026 | 41535900 | PubTator, text mining | PubMed |
| Integrative Human Genomic and Pharmacological Analyses Identify CACNB4 as a Druggable Target for Periodontitis. | J Periodontal Res | 2026 | 41498379 | PubTator, text mining | PubMed |
| Multiomics genetic insights into potential molecular targets for intracranial aneurysm. | Stroke Vasc Neurol | 2026 | 40639910 | PubTator, text mining | PubMed |
| Predicting the unseen: A diffusion-based debiasing framework for transcriptional response prediction at single-cell resolution. | Proc Natl Acad Sci U S A | 2025 | 41452988 | PubTator, text mining | PubMed |
| Prediction of Immunotherapy Response and Prognostic Outcomes for Patients With Ovarian Cancer Using PANoptosis-Related Genes. | Hum Mutat | 2025 | 41141246 | PubTator, text mining | PubMed |
| Uncovering the Molecular Networks of Extracellular Vesicles in the Pathogenesis of Periodontitis. | Int Dent J | 2025 | 41138693 | PubTator, text mining | PubMed |
| Engineering NIR probes to enhance affinity and clinical workflow compatibility for prostate cancer imaging. | bioRxiv | 2025 | 41000778 | PubTator, text mining | PubMed |
| KEY GENETIC DETERMINANTS OF SEPSIS SUSCEPTIBILITY AND SEVERITY: A SYSTEMATIC MULTIDIMENSIONAL ANALYSIS. | Shock | 2025 | 40952416 | PubTator, text mining | PubMed |
| pVHL regulates protein stability of the TCF/LEF transcription factor family via ubiquitin-independent proteasomal degradation. | Cell Mol Life Sci | 2025 | 40906297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5685/papers